Focus of target

CH Robinson’s (CHRW) 10-K will be released by early March at the latest, but we already have enough evidence in its unaudited 8-K filing released recently to draw a very simple conclusion: the patient is on the operating table.

As one of the most prominent brokers of freight services in North America struggles, its competitive advantage in pricing power is eroding, hindering brand power. This comes operationally just as, financially, trying to prop up earnings per share via buybacks at over 5x ...

Subscription required for Premium stories

In order to view the entire article please login with a valid subscription below or register an account and subscribe to Premium

Or buy full access to this story only for £13.00

Please login to activate the purchase link or sign up here to register an account

Premium subscriber
New Premium subscriber REGISTER

Comment on this article


You must be logged in to post a comment.